Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Mucositis 7Obesity 6Polycystic Ovary Syndrome 3Stomatitis 2Head and Neck Neoplasms 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Lipid Metabolism Disorders 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hirsutism 1Endometrial Neoplasms 1Dyspnea 1Drug-Related Side Effects and Adverse Reactions 1Disease 1Diabetes Mellitus 1Colorectal Neoplasms 1

Interventions

Metformin 1Fish Oils 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Lipid Metabolism Disorders × Other × Clear all
NCT04116203 2025-02-28

PCOS

University of Alberta

Phase 1 Completed
52 enrolled
Other

Cardiovascular Diseases, Diabetes Mellitus, Obesity, Polycystic Ovary Syndrome, Lipid Metabolism Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡